Search Results For ''

  • Mighty Kingdom’s largest shareholder warns of bankruptcy, demands Chairperson’s removal at upcoming AGM

    In a story-line fit for a video game, gaming company Mighty Kingdom (ASX: MKL) is set for a drama-packed AGM on November 29 with the Company’s largest shareholder Shane Yeend utilising his massive social network to highlight Mighty Kingdom’s dire financial situation in order to have current Chairperson, Michelle Guthrie, ousted.  In a LinkedIn post

    Read More
    Public
  • Vitura receives first MDMA for its newly-minted psychedelics arm Cortexa

    In May 2023, diversified digital health company Vitura Health (ASX: VIT) announced a joint venture with Canadian psychedelic company PharmAla Biotech, giving birth to its Melbourne-based psychedelics arm, Cortexa. Providing an update on the 50-50 venture, the Company has noted an “Australian first” win. Its MDMA bulk GMP (good manufacturing practice) Active Pharmaceutical Ingredient (API)

    Read More
    Public
  • Parkway partners with Energy Estate to boost sustainability initiatives in Queensland

    Aussie CleanTech company Parkway Corporate (ASX: PWN) and Australian clean energy development firm Energy Estate have entered into a strategic partnership to advance sustainability initiatives in regional Queensland. The partnership seeks to leverage the strengths of both organisations to address several vital opportunities. Key focus areas include renewable energy, green chemicals, and waste disposal, with

    Read More
    Public
  • Can our market shake off the rate rise?

    The XJO is expected to open flat this morning following another small rise in the U.S overnight. Yesterday the RBA raised the cash rate by 25 basis point from 4.1% to 4.35%. The statement was rather wishy-washy, but indicated that they feel we have seen peak inflation and that it would be likely unnecessary to

    Read More
    Public
  • Island Pharmaceuticals receives ethics approval for Dengue fever drug

    The world could soon be one step closer to a preventative for Dengue fever with Island Pharmaceuticals (ASX: ILA), an Australian antiviral drug development company obtaining Human Research Ethics Committee (HREC) approval to initiate its human trials for drug ISLA-101.  This step of the regulatory approval framework is a significant step forward in the Company’s

    Read More
    Public
  • Markets get caught by a triple surprise | Economic Update

    Interest Rates The markets were caught by a triple surprise last week. Firstly, the Treasury opted to issue less 10 and 30-year bonds and more 3-5 year bonds for its refinancing, then the ISM manufacturing and services PMI data was weaker, and finally the non-farm payrolls were weaker than expected. This brought about what looks

    Read More
    Public